国: マレーシア
言語: 英語
ソース: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
METFORMIN HYDROCHLORIDE
MERCK SDN. BHD.
METFORMIN HYDROCHLORIDE
100Tablet Tablets
MERCK SANTE S.A.S.
NA ME O F THE MED I C I NA L PRODUC T G LUC O P HAG E 850 m g f ilm -c oated tablets QUALITATIVE AND QUAN TI TA TI V E C O MP O S I TI O N O n e f ilm -c oated tablet c ontains 850 mg metformin hydroc hloride c orresponding to 662.9 mg metformin bas e. For a full list of exc ipients, see List of Exc ipient s. PHARMACEUTICAL FORM F ilm -c oated tablet. White, c irc ular, c onvex film -c oated tablets . CLINICAL PARTICULARS Therapeutic indications Treatment of type 2 diabetes mellitus, w hen dietary management and exerc ise alone does not result in adequate glyc aemic c ontrol. - In adults, G LUCOPHAGE® 850 mg film -c oated tablet may be used as monotherapy or in c ombination w ith other oral anti -diabetic agents or w ith insulin. - In c hildren from 10 years of age and adoles c ents , GLUCOPHAGE® 850 mg film -c oated tablet may be us ed as mo notherapy or in c ombination w ith insulin. A reduc tion of diabetic c omplic ations has been show n in overw eight type 2 diabetic adult patients treated w ith metformin as first- line therapy after diet failure, s ee Pharmac odynamic properties. Posology and me th od of administration Adults w ith normal renal func tion (GFR ≥ 90mL/min) Monotherapy and combination with other oral antidiabetic agents: - The usual starting dose is one tablet 2 or 3 times daily given during or after meals. After 10 to 15 days the dose should be adjusted on the basis of blood gluc ose measurements. A s low inc reas e of dose may improve gastrointestinal tolerability. 完全なドキュメントを読む